Clinical Trial Update: Synapse 3D With Intravascular Indocyanine Green [Phase 1, Phase 2]

View source ↗

Summary

This update notes a Phase 1/2 trial of Synapse 3D with intravascular indocyanine green that is currently recruiting for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Non-small Cell Lung Cancer, Primary Neoplasm | Phase 1, Phase 2 | Status: RECRUITING